UnknownPhase 4NCT04421495
Safety and Effectiveness of Delamanid-containing Regimen for MDR-TB Patients in China
Studying Tuberculosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Beijing Chest Hospital
- Principal Investigator
- Liang Li, D.M.DBeijing Chest Hospital
- Intervention
- Delamanid(drug)
- Enrollment
- 608 enrolled
- Eligibility
- 18-65 years · All sexes
- Timeline
- 2020 – 2024
Study locations (25)
- Beijing Chest Hospital, Capital Medical University, Beijing, China
- Changsha Central Hospital, Changsha, China
- Public Health Clinical Center of Chengdu, Chengdu, China
- Chongqing Infectious Disease Medical Center, Chongqing, China
- Fuzhou Pulmonary Hospital of Fujian, Fuzhou, China
- Guangzhou Chest Hospital, Guangzhou, China
- Guiyang Public Health Clinical Center, Guiyang, China
- Heilongjiang Province center for tuberculosis Control and Prevention, Haerbin, China
- Hangzhou Red Cross Hospital, Hangzhou, China
- Jiamusi Tumor Hospital, Jiamusi, China
- Tuberculosis Hospital in Jilin Province, Jilin, China
- Shandong Provincial Chest Hospital, Jinan, China
- The Third People's Hospital of Kunming City, Kunming, China
- Lanzhou Pulmonary Hospital, Lanzhou, China
- Longtan Hospital of Guangxi Zhuang Autonomous Region, Liuchow, China
- +10 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04421495 on ClinicalTrials.govOther trials for Tuberculosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07164742Parent Study Name: Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB Pure)Johns Hopkins University
- RECRUITINGNCT0707721318F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis PatientsChildren's Hospital Medical Center, Cincinnati
- RECRUITINGNCT07451899TB Type and Spirometry Result vs. Functional Capacity Based on 6MWT in People With Post-TB Lung DiseaseUniversitas Padjadjaran
- RECRUITINGNCT06845618Blood Tuberculosis DNA Levels to Monitor Tuberculosis TreatmentUniversity of Oxford
- ENROLLING BY INVITATIONNANCT06984887Evaluation of New TB Diagnostic Tests (NATs) in PakistanMercy Corps Pakistan
- RECRUITINGNCT07018076Candidate Clinical Correlate of Prognostic Outcome for TB StudyUniversity of California, San Francisco
- RECRUITINGNANCT07271225Safety and Efficacy of Ear Acupuncture for Antituberculosis Drug-Related Nausea and VomitingIndonesia University
- RECRUITINGNCT06585358DoseTB-individualised Dosing by Model-informed Precision Dosing for Pulmonary TuberculosisKarolinska Institutet